表紙:遺伝子検査の世界市場 - 予測、業界動向、成長率、COVID-19の影響、機会企業分析:2021年~2027年
市場調査レポート
商品コード
1033719

遺伝子検査の世界市場 - 予測、業界動向、成長率、COVID-19の影響、機会企業分析:2021年~2027年

Genetic Testing Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis

出版日: | 発行: Renub Research | ページ情報: 英文 130 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.86円
遺伝子検査の世界市場 - 予測、業界動向、成長率、COVID-19の影響、機会企業分析:2021年~2027年
出版日: 2021年10月01日
発行: Renub Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子検査の市場規模は、2021年の139億2,000万米ドルから、2027年までに250億5,000万米ドルに達し、2021年~2027年のCAGRで10.29%の成長が予測されています。世界の遺伝子検査市場は、遺伝性疾患の患者数の増加と、世界中の重要経済による医療費の増加によって促進されています。

当レポートでは、世界の遺伝子検査業界について調査分析し、タイプ別、技術別、適応別、地域別の詳細のほか、企業分析について、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長促進要因
  • 課題

第5章 世界の遺伝子検査市場

第6章 市場シェア

  • タイプ別
  • 技術別
  • 適応別
  • 地域別

第7章 タイプ - 遺伝子検査市場

  • 予測検査
  • 保因者検査
  • 出生前検査・新生児検査
  • 診断検査
  • 薬理ゲノミクス検査
  • ニュートリゲノミクス検査
  • その他

第8章 技術 - 遺伝子検査市場

  • 細胞遺伝学的検査
  • 生化学的検査
  • 分子検査

第9章 適応 - 遺伝子検査市場

  • がん
  • 遺伝性疾患
  • 心血管疾患
  • その他

第10章 地域 - 遺伝子検査市場

  • 欧州
  • アメリカ

第11章 ラボ数:47ヶ国別 (遺伝子検査レジストリ)

第12章 企業分析

  • Abbott Laboratories
  • Danaher Corporation (Cepheid Inc.)
  • Illumina Inc.
  • BioRad Laboratories Inc.
  • F Hoffmann-La Roche AG
図表

List of Figures

  • Figure-01: Global Genetic Testing Market (Billion US$), 2018 - 2021
  • Figure-02: Forecast for - Global Genetic Testing Market (Billion US$), 2022 - 2027
  • Figure-03: Type - Predictive Testing Market (Million US$), 2018 - 2021
  • Figure-04: Type - Forecast for Predictive Testing Market (Million US$), 2022 - 2027
  • Figure-05: Type - Carrier Testing Market (Million US$), 2018 - 2021
  • Figure-06: Type - Forecast for Carrier Testing Market (Million US$), 2022 - 2027
  • Figure-07: Type - Prenatal and Newborn Testing Market (Billion US$), 2018 - 2021
  • Figure-08: Type - Forecast for Prenatal and Newborn Testing Market (Billion US$), 2022 - 2027
  • Figure-09: Type - Diagnostic Testing Market (Billion US$), 2018 - 2021
  • Figure-10: Type - Forecast for Diagnostic Testing Market (Billion US$), 2022 - 2027
  • Figure-11: Type - Pharmacogenomic Testing Market (Million US$), 2018 - 2021
  • Figure-12: Type - Forecast for Pharmacogenomic Testing Market (Million US$), 2022 - 2027
  • Figure-13: Type - Nutrigenomic Testing Market (Million US$), 2018 - 2021
  • Figure-14: Type - Forecast for Nutrigenomic Testing Market (Million US$), 2022 - 2027
  • Figure-15: Type - Others Market (Million US$), 2018 - 2021
  • Figure-16: Type - Forecast for Others Market (Million US$), 2022 - 2027
  • Figure-17: Technology - Cytogenetic Testing Market (Billion US$), 2018 - 2021
  • Figure-18: Technology - Forecast for Cytogenetic Testing Market (Billion US$), 2022 - 2027
  • Figure-19: Technology - Biochemical Testing Market (Billion US$), 2018 - 2021
  • Figure-20: Technology - Forecast for Biochemical Testing Market (Billion US$), 2022 - 2027
  • Figure-21: Technology - Molecular Testing Market (Billion US$), 2018 - 2021
  • Figure-22: Technology - Forecast for Molecular Testing Market (Billion US$), 2022 - 2027
  • Figure-23: Application - Cancer Market (Billion US$), 2018 - 2021
  • Figure-24: Application - Forecast for Cancer Market (Billion US$), 2022 - 2027
  • Figure-25: Application - Genetic Diseases Market (Billion US$), 2018 - 2021
  • Figure-26: Application - Forecast for Genetic Diseases Market (Billion US$), 2022 - 2027
  • Figure-27: Application - Cardiovascular Diseases Market (Billion US$), 2018 - 2021
  • Figure-28: Application - Forecast for Cardiovascular Diseases Market (Billion US$), 2022 - 2027
  • Figure-29: Application - Others Market (Billion US$), 2018 - 2021
  • Figure-30: Application - Forecast for Others Market (Billion US$), 2022 - 2027
  • Figure-31: Europe - Genetic Testing Market (Billion US$), 2018 - 2021
  • Figure-32: Europe - Forecast for Genetic Testing Market (Billion US$), 2022 - 2027
  • Figure-33: America - Genetic Testing Market (Billion US$), 2018 - 2021
  • Figure-34: America - Forecast for Genetic Testing Market (Billion US$), 2022 - 2027
  • Figure-35: Middle East & Africa - Genetic Testing Market (Million US$), 2018 - 2021
  • Figure-36: Middle East & Africa - Forecast for Genetic Testing Market (Million US$), 2022 - 2027
  • Figure-37: Asia-Pacific - Genetic Testing Market (Billion US$), 2018 - 2021
  • Figure-38: Asia-Pacific - Forecast for Genetic Testing Market (Billion US$), 2022 - 2027
  • Figure-39: Abbott Laboratories - Global Revenue (Billion US$), 2018 - 2021
  • Figure-40: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-41: Danaher Corporation (Cepheid Inc.) - Global Revenue (Billion US$), 2018 - 2021
  • Figure-42: Danaher Corporation (Cepheid Inc.) - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-43: Illumina Inc. - Global Revenue (Billion US$), 2018 - 2021
  • Figure-44: Illumina Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-45: BioRad Laboratories Inc. - Global Revenue (Billion US$), 2018 - 2021
  • Figure-46: BioRad Laboratories Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-47: F Hoffmann-La Roche AG - Global Revenue (Billion US$), 2018 - 2021
  • Figure-48: F Hoffmann-La Roche AG - Forecast for Global Revenue (Billion US$), 2022 - 2027

List of Tables

  • Table-01: Global - Genetic Testing Market Share by Type (Percent), 2018 - 2021
  • Table-02: Global - Forecast for Genetic Testing Market Share by Type (Percent), 2022 - 2027
  • Table-03: Global - Genetic Testing Market Share by Technology (Percent), 2018 - 2021
  • Table-04: Global - Forecast for Genetic Testing Market Share by Technology (Percent), 2022 - 2027
  • Table-05: Global - Genetic Testing Market Share by Application (Percent), 2018 - 2021
  • Table-06: Global - Forecast for Genetic Testing Market Share by Application (Percent), 2022 - 2027
  • Table-07: Global - Genetic Testing Market Share by Region (Percent), 2018 - 2021
  • Table-08: Global - Forecast for Genetic Testing Market Share by Region (Percent), 2022 - 2027
  • Table-09: Number of Labs by Countries (Genetic Testing Registry)
目次

Genetics is the research of genes, their functions and their impacts. Among the numerous types of genetics such as molecular genetics, population genetics, developmental genetics and quantitative genetics, human genetics deals with the inheritance in human beings. Further, genetic testing is defined as medical devices available in kits and panels used to test genetic diseases in humans. Where in the testing is conducted by accumulating samples of blood of patients. These samples are later run on laboratory machines utilizing test kits.

Global Genetic Testing Market is expected to reach US$ 25.05 Billion by 2027

Remarkably, the genetic testing market has experienced rapid growth in the past few years. Prominently, the global genetic testing market is driven by the increasing number of patients with genetic diseases and increasing healthcare expenditure by significant economies across the globe. Besides, the growing awareness about genetic conditions, rising investments in research and development, and increasing government support further fuel the market growth. In addition, the increasing technological advancements from the past few years have opened up several opportunities for market expansion.

Suppressing Impact of COVID-19 on the Worldwide Genetic Testing Market

The COVID-19 pandemic has left a notable impact on the growth of the genetic testing market over the crisis. According to the research article issued in Genetics in Medicine 2020, all the clinical genetic testing was limited, and telemedicine-based deliberations and counselling were ratified globally. As per the study, 112 prenatal and 156 clinical genetics/cancer patients were evaluated in one month at the Columbia University Irving Medical Center (CUIMC).

In addition, most genetic testing services have adopted virtualization and home testing kit/home sample collection to oppose the transmission of the SARS-CoV2 virus. Hence, COVID-19 is expected to, directly and indirectly, impact the genetic testing market over the ongoing crisis period.

Global Genetic Testing Market Size was US$ 13.92 Billion in 2021

By type, the market comprises Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing and Nutrigenomic Testing. Diagnostic testing is used to analyze or rule out a precise genetic or chromosomal condition. In multiple cases, genetic testing is employed to declare a diagnosis when a particular disease is doubted based on visible signs and symptoms. Diagnostic testing can be conducted before birth or at any time throughout a person's life but is not possible for all genes or all genetic tones. As per our study, the diagnostic testing segment held the dominant position and is envisioned to persevere its dominance during the forecast period (2021-2027).

Globally Genetic Testing Industry is expected to grow with a CAGR of 10.29% from 2021 to 2027

By technology, the market comprises Cytogenetic Testing, Biochemical Testing and Molecular Testing. Where in molecular testing is the most used technology for genetic testing. Molecular Diagnostics is the latest watchword in the field of Diagnostics and is now touching all areas of medicine. Molecular Diagnostics studies of DNA/RNA of the organism and thus looks at the fundamental unit of disease prediction, detection and cure. For instance, molecular technology is used in genetic tests such as carrier testing, diagnostic testing, predictive & pre-symptomatic testing. On the other hand, as per our analysis, Prenatal and Newborn-Testing also have a significant market share. This is attributable to advancements in awareness regarding healthcare and an increase in the mortality rate from genetic diseases worldwide.

Genetic Testing helps in Early Detection of Cancer

By Application - Genetic Testing Market works for Cancer, Genetic Diseases and Cardiovascular Diseases. For cancer, genetic testing helps identify the uncertainty of acquiring various types of cancers during the individual's endurance. Genetic tests are open to testing inherited variants and deviations in the DNA sequence, leading to excessive cells and tumour/cancer growth. For instance, genetic testing for the classification of PALB2 (affiliated with increased uncertainties of breast and pancreatic cancers), BRIP1 (ovarian cancer), CHEK2 (breast and colorectal cancers) and RAD51C and RAD51D (ovarian cancer) are done.

The growing burden of cancers universally and the growing consciousness among the global population on precautionary diagnosis and personalized medication are the major factors driving the cancer segment market over the forecast period. Also, the booming technological elevations and product launches anticipate encouraging the studied fragment. For example, in December 2020, Roche launched the Cobas PIK3CA Mutation Test to identify PIK3CA variations in patients with exceptional or metastatic breast cancer. Consequently, the cancer segment is expected to witness significant growth over the forecast period because of the factors mentioned above.

United States & Europe are the Leaders in Genetic Testing Industry

By Region, the American market for human genetics is inferable from advancements in diagnostics and medicinal reform and broad utilization of new advances in genetics. Furthermore, the nearness of critical players in the market likewise fills the market development. In recent years, the European market for human genetics has been driven by the rising pervasiveness of various unending hereditary infections and expanding government support for innovative work exercises. In Germany, the most significant market, the increasing spotlight represents the development of research exercises by real market players in genetics and innovative headway.

Moreover, the market in the Asia Pacific is energized by the expanding mindfulness about research in congenital infections and consistent ascent in the predominance of hereditary illnesses. Powerful nations adding to the market development are China, Japan, and India because of expanding the accessibility of research offices and nearness of talented workforce, for example, explore researchers and others.

The global genetic testing market is highly aggressive, and the prominent players have adopted multiple strategies to garner maximum genetic testing market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market are Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc. and F Hoffmann-La Roche AG.

Renub Research latest report "Genetic Testing Market, Global Forecast By Type (Predictive Testing, Carrier Testing, Prenatal and New-born Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing and Others), Technology (Cytogenetic Testing, Biochemical Testing and Molecular Testing), Application (Cancer, Genetic Diseases, Cardiovascular Diseases and Others), Region (Europe, America, Middle East & Africa and Asia-Pacific), Companies (Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc. and F Hoffmann-La Roche AG.)" provides a detailed analysis of Global Genetic Testing Market.

Type - Genetic Testing Markethas been covered from 7 viewpoints:

  • 1. Predictive Testing
  • 2. Carrier Testing
  • 3. Prenatal and New-born Testing
  • 4. Diagnostic Testing
  • 5. Pharmacogenomics Testing
  • 6. Nutrigenomic Testing
  • 7. Others

Technology - Genetic Testing Market has been covered from 3 viewpoints:

  • 1. Cytogenetic Testing
  • 2. Biochemical Testing
  • 3. Molecular Testing

Application - Genetic Testing Market has been covered from 4 viewpoints:

  • 1. Cancer
  • 2. Genetic Diseases
  • 3. Cardiovascular Diseases
  • 4. Others

Region - Genetic Testing Market has been covered from 4 viewpoints:

  • 1. Europe
  • 2. America
  • 3. Middle East & Africa
  • 4. Asia-Pacific

Company Insights:

    • Overview
    • Recent Development & Strategies
    • Financial Insights

Company Covered:

  • 1. Abbott Laboratories
  • 2. Danaher Corporation (Cepheid Inc.)
  • 3. Illumina Inc.
  • 4. BioRad Laboratories Inc.
  • 5. F Hoffmann-La Roche AG

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Genetic Testing Market

6. Market Share

  • 6.1 By Type
  • 6.2 By Technology
  • 6.3 By Application
  • 6.4 By Region

7. Type - Genetic Testing Market

  • 7.1 Predictive Testing
  • 7.2 Carrier Testing
  • 7.3 Prenatal and New-born Testing
  • 7.4 Diagnostic Testing
  • 7.5 Pharmacogenomics Testing
  • 7.6 Nutrigenomic Testing
  • 7.7 Others

8. Technology - Genetic Testing Market

  • 8.1 Cytogenetic Testing
  • 8.2 Biochemical Testing
  • 8.3 Molecular Testing

9. Application - Genetic Testing Market

  • 9.1 Cancer
  • 9.2 Genetic Diseases
  • 9.3 Cardiovascular Diseases
  • 9.4 Others

10. Region - Genetic Testing Market

  • 10.1 Europe
  • 10.2 America

11. Number of Labs by 47 Countries (Genetic Testing Registry)

12. Company Analysis

  • 12.1 Abbott Laboratories
    • 12.1.1 Overview
    • 12.1.2 Recent Development
    • 12.1.3 Financial Insights
  • 12.2 Danaher Corporation (Cepheid Inc.)
    • 12.2.1 Overview
    • 12.2.2 Recent Development
    • 12.2.3 Financial Insights
  • 12.3 Illumina Inc.
    • 12.3.1 Overview
    • 12.3.2 Recent Development
    • 12.3.3 Financial Insights
  • 12.4 BioRad Laboratories Inc.
    • 12.4.1 Overview
    • 12.4.2 Recent Development
    • 12.4.3 Financial Insights
  • 12.5 F Hoffmann-La Roche AG
    • 12.5.1 Overview
    • 12.5.2 Recent Development
    • 12.5.3 Financial Insights